Taiqian J. Gong
Beijing, 100048, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Engineering L-Arg@ZIF-8 nanoparticles to modulate the immune-osteogenic-angiogenic microenvironment for accelerated bone fracture healing.
Journal: Discover nano
Published: December 16, 2025
A mediastinal eosinophilic adenoma misdiagnosed as an esophageal stromal tumor: A case report.
Journal: Journal of cardiothoracic surgery
Published: February 17, 2025
TESC acts as a prognostic factor and promotes epithelial-mesenchymal transition progression in esophageal squamous carcinoma.
Journal: Pathology, research and practice
Published: October 30, 2023
Monoclonal Antibody Targeting CGRP Relieves Cisplatin-Induced Neuropathic Pain by Attenuating Neuroinflammation.
Journal: Neurotoxicity research
Published: October 28, 2023
FAM107A as a tumor suppressor in esophageal squamous carcinoma inhibits growth and metastasis.
Journal: Pathology, research and practice
Published: October 24, 2023
JAM2 is a prognostic biomarker and inhibits proliferation, metastasis and epithelial-mesenchymal transition in lung adenocarcinoma.
Journal: The journal of gene medicine
Published: October 06, 2023
Tumor associated macrophages in esophageal squamous carcinoma: Promising therapeutic implications.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: August 16, 2023
ASO Author Reflections: 3-Year Survival Outcomes of Lymphadenectomy in Minimally Invasive Esophagectomy.
Journal: Annals of surgical oncology
Published: June 13, 2023
18 F-FDG PET/CT predicts the role of neoadjuvant immunochemotherapy in the pathological response of esophageal squamous cell carcinoma.
Journal: Thoracic cancer
Published: April 11, 2023
Three-Field Versus Two-Field Lymphadenectomy in Minimally Invasive Esophagectomy: 3-Year Survival Outcomes of a Randomized Trial.
Journal: Annals of surgical oncology
Published: March 19, 2023
Last Updated: 09/26/2026